Recent
- ‘Right To Try Laws’ and Legal Access to Psilocybin Therapy with Dr. Jonathan Fields
- Compass Pathways Phase 2 Psilocybin Results far from Spectacular
- Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks Drop
- Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS
- Psychedelic Stocks: ARK Invest and the Reverse Midas Touch
- Compass Pathways Sued for Stealing Trade Secrets
- Three Phase 3 Clinical Trials that Could Legalize Psychedelics
- A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
- Compass Pathways Appoints a New CEO
- Compass Pathways Psilocybin Patent Upheld
COMPASS Pathways
Public Company
[stockdio-historical-chart symbol="CMPS" stockExchange="" palette="financial-light"]